NCT05237817 Association Between Stroke and Adrenal Incidentalomas
| NCT ID | NCT05237817 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 2 participants |
| Start Date | 2021-04-01 |
| Primary Completion | 2022-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2 participants in total. It began in 2021-04-01 with a primary completion date of 2022-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Adrenal incidentalomas (AIs) are commonly encountered in transsection imaging which purpose not for suspected adrenal disease. However, part of AIs in patients is associated with Stroke. Stroke is a diseases which could cause of disability and death worldwide. In clinical practice, detailed information about the association between stroke and AIs is not available. In this study, the investigators aimed to investigate the risk for disability and death in the large group of stroke patients with AIs.
Eligibility Criteria
Inclusion Criteria: * stroke disease , such as Cerebral infarction、Intracerebral hemorrhage and Subarachnoid hemorrhage. Exclusion Criteria: * presence of metastatic cancer; * AIs smaller than 1 cm; * nonadenoma lesions, such as myelolipomas,hemorrhages, and cysts; * oral glucocorticoid treatment with more than single doses in the past 3 months; * use of inhaled steroids or medication affecting dexamethasone metabolism; * systemic estrogen treatment.
Contact & Investigator
Tong W Ou, Dr.
STUDY DIRECTOR
Department of Urology, Xuanwu Hospital, Capital Medical University
Frequently Asked Questions
Who can join the NCT05237817 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05237817 currently recruiting?
Yes, NCT05237817 is actively recruiting participants. Contact the research team at yanhurology@qq.com for enrollment information.
Where is the NCT05237817 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05237817 clinical trial?
NCT05237817 is sponsored by Xuanwu Hospital, Beijing. The principal investigator is Tong W Ou, Dr. at Department of Urology, Xuanwu Hospital, Capital Medical University. The trial plans to enroll 2 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.